Showing results (11-20 of 196) with videos related to
Sort By:
Pageof 20
Critical Care Medicine|June 29, 2016
Differences in Impact of Definitional Elements on Mortality Precludes International Comparisons of Sepsis Epidemiology-A Cohort Study Illustrating the Need for Standardized ReportingManu Shankar-Hari, David A Harrison, Kathryn M RowanClinics in Chest Medicine|October 23, 2024
Steroids and Immunomodulatory Therapies for Acute Respiratory Distress SyndromeJonathan E Millar, Thomas H Craven, Manu Shankar-HariImmunity|November 10, 2021
The immunology of sepsisTom van der Poll, Manu Shankar-Hari, W Joost WiersingaIntensive Care Medicine Experimental|December 29, 2021
Towards an ecological definition of sepsis: a viewpointMichael Bauer, Manu Shankar-Hari, Daniel O Thomas-Rüddel, et al.Critical Care Medicine|January 25, 2019
Readmission Diagnoses After Pediatric Severe Sepsis HospitalizationErin F Carlton, Joseph G Kohne, Manu Shankar-Hari, et al.Journal of Critical Care|February 8, 2018
Estimating attributable fraction of mortality from sepsis to inform clinical trialsManu Shankar-Hari, David A Harrison, Kathryn M Rowan, et al.Journal of Hepatology|July 21, 2009
Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?Banwari Agarwal, Steve Shaw, Manu Shankar Hari, et al.Critical Care (London, England)|April 18, 2018
Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot studyJulie K Wilson, Yuan Zhao, Mervyn Singer, et al.Journal of the Intensive Care Society|March 2, 2023
Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, "ABC-Sepsis"John Cafferkey, Andrew Ferguson, Julia Grahamslaw, et al.Critical Care (London, England)|March 20, 2012
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveManu Shankar-Hari, Jo Spencer, William A Sewell, et al.Pageof 20